FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion

  • 0Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai, 200032, China.

|

|

Summary

This summary is machine-generated.

Elevated N6-methyladenosine (m6A) levels correlate with poor prognosis in hepatocellular carcinoma (HCC). The demethylase FTO acts as a tumor suppressor, with its downregulation promoting HCC progression and metastasis.

Area Of Science

  • Epigenetics
  • Cancer Biology
  • Molecular Oncology

Background

  • N6-methyladenosine (m6A) modification dysregulation is linked to various cancers, including hepatocellular carcinoma (HCC).
  • The role of m6A in HCC prognosis and its underlying molecular mechanisms, especially involving the FTO demethylase, remain to be fully elucidated.

Purpose Of The Study

  • To investigate the prognostic significance of m6A modifications in HCC.
  • To explore the functional role and molecular mechanisms of the FTO demethylase in HCC progression and metastasis.

Main Methods

  • Analyzed m6A expression in 323 HCC patients via immunohistochemistry (IHC).
  • Quantified m6A-related gene expression (FTO, ALKBH5, METTL3, METTL14) in 120 paired HCC tissues using qRT-PCR.
  • Assessed FTO's impact on HCC cell behavior (proliferation, invasion, metastasis) in vitro and in vivo using genetically modified cell lines and mouse models.

Main Results

  • Elevated m6A levels were observed in 57.3% of HCC tissues and correlated with poorer overall survival and recurrence-free survival.
  • FTO demethylase was significantly downregulated in HCC, particularly in metastatic cell lines.
  • FTO overexpression suppressed HCC cell proliferation, migration, and invasion, and reduced tumor growth/metastasis in vivo, partly via downregulation of VEGFA.

Conclusions

  • Aberrant m6A modifications, driven by FTO downregulation, promote HCC progression and metastasis.
  • FTO functions as a tumor suppressor in HCC by negatively regulating VEGFA, suggesting its therapeutic potential.
  • m6A modifications are significant in HCC, providing a basis for developing targeted therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression 03:03

3.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Receptor Downregulation in MVBs 01:15

2.0K

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...

MicroRNAs 01:22

2.9K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Master Transcription Regulators 02:23

6.7K

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

Abnormal Proliferation 02:23

4.3K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Regulation of Angiogenesis and Blood Supply 01:24

2.5K

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...